Amgen Ventures — Full Portfolio

Generate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering.

AI & Machine LearningBiotechDeep TechSomerville, US

GGGevorg Grigoryan(Founder)inMNMichael Nally(Chief Executive Officer)inAvak Kahvejian(Founder)Geoffrey von Maltzahn(Founder)Molly Gibson(Founder)

Co-investorsFLFlagship PioneeringALAlumni VenturesARARCH Venture PartnersMAMarch Capital PartnersNVNVIDIAALAlaska Permanent Fund Corporation+4 more

Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.

BiotechDeep TechDigital HealthMedical DevicesWatertown, US

PLPaul L. Berns(Chairman and Chief Executive Officer)Joshua Pinto(Executive Officer)TTTamara Tompkins(Executive Officer)inKari Stefansson(Director)MHMaykin Ho(Director)AHAlaa Halawa(Director)

Co-investorsARARCH Venture PartnersCACatalio Capital Management, LPF-F-Prime CapitalK2K2 HealthVenturesMEMercury FundPRPremier Partners+12 more

Nkarta is a biotech company developing allogeneic CAR NK cell therapies for autoimmune diseases, aiming to offer safer and more accessible alternatives to autologous CAR-T treatments.

BiotechHealthtechSouth San Francisco, US

PHPaul Hastings(Executive Officer, Director)inPaul H.inMatthew Plunkett(Executive Officer)in

BoardMichael Dybbs(Director)JCJill Carroll(Director)inTATiba Aynechi(Director)in

Co-investorsNENew Enterprise Associates (NEA)RARA CapitalSASamsara BioCapitalSRSR One Capital ManagementLOLogosNONorwest Venture Partners+1 more

Senti Bio develops cell and gene therapies for cancer and difficult-to-treat diseases using synthetic biology and engineered Gene Circuits to enhance precision, control, and selectivity in targeting tumor cells.

BiotechDeep TechMedical DevicesSouth San Francisco, US

TLTim Lu(Co-Founder and Chief Executive Officer)inPLPhilip Lee(Executive Officer)inKanya Rajangam(President, Head of Research & Development and Chief Medical Officer)inYLYvonne Li(Executive Officer)inJames Collins(Director)Timothy Lu(Founder)

Co-investorsEVEvolution VC PartnersFLFlucas VenturesGAGaingelsGRGreen Sands EquityLILifeforce CapitalLILifeSci Venture Partners+13 more

The Amgen Foundation funds and runs science education programs, providing teachers with research equipment and training and offering hands-on and virtual learning opportunities to students and scholars.

BiotechEdTechImpact & Social Good

Big Hat Bio develops therapeutics under development across multiple programs.

AI & Machine LearningBiotechDeep TechSan Francisco, US

PGPeyton Greenside(Founder)inMDMark DePristo(Founder)inMark DePristo Peyton Greenside(Founder)Theresa Tribble(Founder)

BoardFGFrancisco Gimenez(Director)inSKSteve Kafka(Director)

Co-investors8V8VCANAndreessen HorowitzBOBOLD LongevityFLFlucas VenturesGAGaingelsGRGRIDS Capital+12 more

Calistoga Pharmaceuticals is a pharmaceutical company.

BiotechHealthtechSeattle, US

Co-investorsFRFrazier Life SciencesALAlta PartnersFRFrazier Healthcare Partners

Cartography develops antibody-based cancer therapies using single-cell sequencing and computational biology to identify precise cellular targets.

AI & Machine LearningBiotechDeep TechMedical DevicesSouth San Francisco, US

MMMax Mumbach(Founding Scientist, Target Discovery)inJVJeffrey Verboon(Founding Scientist, Computational Biology)inASAnsu Satpathy(Founder)KPKevin Parker, PhD(Chief Executive Officer, Board Director; co-founder)ASAnsuman Satpathy, MD, PhD(Co-founder; Board Director)HCHoward Chang(Founder)in

Co-investors8V8VCANAndreessen HorowitzARArtis VenturesCACatalio Capital Management, LPFIFinchley Healthcare VenturesGAGaingels+9 more

CatenaBio develops precision conjugation technology using native amino acids to enable biotherapeutic fusions of small molecules, nucleic acids, enzymes, and cells.

BiotechDeep TechHealthtechMedical DevicesBerkeley, US

MLMarco Lobba(Founder)inMatthew Francis(Founder)inGeo Guillen

Co-investorsCACalifornia Innovation FundCICivilization Ventures Management, LlcCRCreative Destruction Lab (CDL)FRFREEFLOWGAGaingelsIAIaso Ventures+14 more

Code Biotherapeutics develops a proprietary non-viral 3DNA delivery platform for genetic medicines, RNAi, and other modalities, using targeting molecules to reach specific cells and tissues outside the liver.

BiotechDeep TechHealthtechHatfield, US

Lauren Kaskiel(Executive Officer)inRobert C. Getts(Executive Officer)BMBrian McVeigh(Executive Officer, Director)in

BoardDmitry Kuzmin(Director)Victor Stone(Director)Edward Mathers(Director)

Co-investorsNENew Enterprise Associates (NEA)4B4BIO CapitalHAHatteras Venture PartnersJDJDRF T1D FundNONorthpond VenturesTATakeda Ventures+1 more

Intermountain Health is a healthcare provider offering primary, pediatric, and specialty care services to patients, with a focus on preventive care and wellness.

Digital HealthHealthtech

Co-investorsEPEPIC VENTURESMEMerck Global Health Innovation Fund

Ember Life Sciences applies its temperature-control heating and cooling technology to healthcare logistics through the Ember Cube, a self-refrigerated, cloud-based shipping box with real-time location tracking and temperature monitoring for cold-chain payloads at 2°C–8°C.

HealthtechIoTLogistics & Supply ChainWestlake Village, US

Clayton Alexander(Executive Officer, Director)Brian Bejarano(Executive Officer)inAnn Marie Hyllengren(Executive Officer)

BoardMichael Kaufmann(Director)Timothy White(Director)James DeNaut(Director)

Co-investorsCACarrier VenturesSESea Court CapitalTDTDF Ventures

EnClear Therapies is a bio/med-tech company developing the EnTrega CSF platform, focused on cerebrospinal fluid-related therapies.

BiotechDigital HealthHealthtechMedical DevicesCambridge, US

ADAnthony DePasqua(Executive Officer, Director)inKKKevin Kalish(COO)inMGMarcie Glicksman(VP Biology)inWilliam Gormley(CMO)Jason Camm(Director)KRKasper Roet(Director)in

Co-investors2020/20 HealthCare Partners LLCDODolby Family VenturesFLFlucas VenturesTATachyon VenturesVUVU Venture PartnersBIBioverge+1 more

Gandeeva Therapeutics uses AI, machine learning, and atomic-resolution cryo-EM imaging to map druggable protein interactions and design molecular glues that bind at specific protein interfaces.

AI & Machine LearningBiotechDeep TechDigital Health

SSSriram Subramaniam(Founder)in

Co-investorsAIAir Street CapitalLULux CapitalOBObvious VenturesAMAmplitude Venture CapitalLELeaps by Bayer

Genome Medical provides telehealth-enabled genetic services, including genetic counseling, genetic testing, and clinical trial matching, with a focus on individuals with rare conditions.

BiotechDigital HealthHealthtechSouth San Francisco, US

LALisa Alderson(Executive Officer, Director)inRandal Scott(Director)Jill Davies(Executive Officer, Director)inEMElizabeth Moreno(Executive Officer)inMSMark Sylvester(Chief Financial Officer)inAWAndrew Warner(Vice President, Product)in

Co-investorsALAlumni VenturesAVAvestria VenturesCACanaan PartnersDRDreamers VCECEcho Health VenturesGVGV (Google Ventures)+11 more

HealthtechCambridge, US

CHCOLIN HILL(Executive Officer, Director)inIKIYA KHALIL(Executive Officer)inTNTHOMAS NEYARAPALLY(Executive Officer)MARK POTTLE(Executive Officer)inCMCAROL MCCALL(Executive Officer)inBRUCE CHURCH(Executive Officer)in

Co-investorsALAlexandriaECEcho Health Ventures

BiotechRichmond, US

Michael D. Grisham(Chief Executive Officer)in

Co-investorsVEVensana Capital

OLG Machinery, founded in 2008, trades new and certified used industrial spare parts and machinery, serving U.S. companies operating across North and South America with a focus on Mexico.

Advanced ManufacturingB2B MarketplacesLogistics & Supply Chain

Co-investorsOXOxford Investment Opportunity Network (OION)ALAlly Bridge GroupALAltium CapitalDRDroia VenturesFRFrazier Healthcare PartnersNONovo Holdings+2 more

Hummingbird Bioscience is a precision biotherapeutics company developing a pipeline of novel targeted therapies for cancer, using proprietary drug discovery technologies and platforms.

AI & Machine LearningBiotechDeep TechHealthtech

PIPiers Ingram(Chief Executive Officer, Co-Founder, Executive Director)inJBJerome Boyd-Kirkup(Chief Scientific Officer, Co-Founder)inKonrad Paszkiewicz(Chief Technology Officer)inKwek Kon Yew(Chief Medical Officer)DTDipti Thakkar(Chief Operating Officer)in

Co-investorsALAltium CapitalCLClavystBioDEDecheng CapitalDRDroia VenturesFRFrazier Life SciencesKIKiwoom Investment+6 more

A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments.

BiotechHealthtech

Co-investorsFRFrazier Life SciencesHIHighlight CapitalMRMRL Ventures FundXEXeraya CapitalBLBlackRockBLBlackstone Life Sciences+5 more

Portfolio company acquired by Novo Nordisk for $1.1B USD.

Co-investorsAMAmorChemGEGenesys CapitalJDJDRF T1D FundNENew Enterprise Associates (NEA)TATarnagulla VenturesADadMare BioInnovations+2 more

Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.

AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US

YEYusuf Erkul(Founder)inJOJeff Ozdemir(Founder)inBYBurak Yilmaz(Founder)inCMCatherine Moroski(Executive Officer, Director)inOguzhan Yilmas(Director)BYBurak YILMAZ(Founder)in

Co-investorsASAsymmetry VenturesCICivilization Ventures Management, LlcFOFoundersX VenturesGAGaingelsHOHOF CapitalHUHummingbird Ventures+13 more

Mindset Medical develops medical-grade software that uses remote photoplethysmography (rPPG) and deep learning to measure vital signs such as heart rate and respiratory rate through the camera on a patient's own smartphone, tablet, or computer.

AI & Machine LearningDigital HealthHealthtechMedical DevicesPhoenix, US

Mark L. Whitehouse(Executive Officer)inMitchell A. Foster(Executive Officer, Director, Promoter)NTNicholas Theodore(Director)Joel Barthelemy(Director)

BoardJGJAMES GOULKA(Director)inBBBRIAN BURNS(Director)in

Co-investorsGRGrayhawk CapitalAZAZ Venture Capital Inc.NONOVA PrimeQUQuesta CapitalXCXcellerant Ventures

QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.

BiotechDeep TechMedical DevicesCambridge, US

KEKevin Eggan(Founder, QurAlis; Group Vice President, Head of Research and Early Development, BioMarin Pharmaceutical)inRoet(Co-founder)Woolf(Co-founder)KRKasper Roet(Founder, Chief Executive Officer)inSVShafique Virani(Executive Officer)inJBJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in

Co-investorsALALS Investment FundDODolby Family VenturesDRDroia VenturesINInkefMCMC Healthcare VenturesMIMission Biocapital+8 more

Develops programmable mRNA therapies that last longer and target cells more precisely for cancer and other diseases.

BiotechBoston, US

TKTasuku Kitada(Executive Officer, Director, Promoter)inJBJacob Becraft(Executive Officer, Director, Promoter)inSamta Kundu(Executive Officer)in

BoardJKJeb Keiper(Director)inAAAla Alenazi(Director)inPEPegah Ebrahimi(Director)in

Co-investorsJIJIC Venture Growth InvestmentsKIKinnevikPLPlayground GlobalANANRIFPFPVICICONIQ+3 more

Strand is a clinical-stage biotechnology company developing programmable mRNA therapeutics for cancers and autoimmune diseases.

AI & Machine LearningBiotechMedical DevicesBoston, US

JBJacob Becraft(CEO, Co-Founder)inTKTasuku Kitada(President, Head of R&D, Co-founder)inRon Weiss(Scientific Co-founder)inDJDarrell J. Irvine(Scientific Co-founder)inPrashant Nambiar(Chief Scientific Officer)ECEthan Cash(Senior Vice President, Head of Portfolio Management and Program Development)in

Co-investorsATAtinum Investment Co. Ltd.FPFPVLGLG Technology VenturesPLPlayground GlobalPOPotentum PartnersALAlix Ventures+5 more